Candriam S.C.A. Trims Position in The Allstate Corporation $ALL

Candriam S.C.A. trimmed its position in The Allstate Corporation (NYSE:ALL) by 9.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 149,091 shares of the insurance provider’s stock after selling 15,222 shares during the period. Candriam S.C.A.’s holdings in Allstate were worth $32,002,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ALL. Harbor Capital Advisors Inc. increased its holdings in Allstate by 79.7% during the third quarter. Harbor Capital Advisors Inc. now owns 124 shares of the insurance provider’s stock valued at $27,000 after buying an additional 55 shares during the last quarter. Barnes Dennig Private Wealth Management LLC increased its stake in shares of Allstate by 112.3% in the 3rd quarter. Barnes Dennig Private Wealth Management LLC now owns 138 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 73 shares in the last quarter. Clearstead Trust LLC raised its holdings in Allstate by 3,800.0% in the 2nd quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 152 shares during the period. Armstrong Advisory Group Inc. grew its holdings in Allstate by 72.0% during the third quarter. Armstrong Advisory Group Inc. now owns 160 shares of the insurance provider’s stock valued at $34,000 after purchasing an additional 67 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its position in Allstate by 315.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after buying an additional 126 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Stock Performance

NYSE ALL opened at $199.91 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.37 and a quick ratio of 0.43. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $216.75. The business has a 50 day simple moving average of $203.68 and a two-hundred day simple moving average of $203.92. The stock has a market capitalization of $52.31 billion, a PE ratio of 5.23, a P/E/G ratio of 0.45 and a beta of 0.24.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share for the quarter, beating analysts’ consensus estimates of $8.72 by $5.59. Allstate had a net margin of 15.19% and a return on equity of 39.20%. The firm had revenue of $14.57 billion during the quarter, compared to analyst estimates of $17.23 billion. During the same period last year, the firm posted $7.67 earnings per share. Allstate’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, research analysts predict that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Monday, March 2nd. This is an increase from Allstate’s previous quarterly dividend of $1.00. Allstate’s dividend payout ratio is 10.47%.

Insider Buying and Selling at Allstate

In other news, insider Suren Gupta sold 19,593 shares of the company’s stock in a transaction dated Wednesday, January 7th. The shares were sold at an average price of $210.00, for a total transaction of $4,114,530.00. Following the sale, the insider directly owned 100,646 shares in the company, valued at approximately $21,135,660. This represents a 16.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last 90 days, insiders have sold 48,400 shares of company stock valued at $10,313,256. Insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ALL. JPMorgan Chase & Co. boosted their price objective on Allstate from $260.00 to $263.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Wells Fargo & Company increased their price objective on shares of Allstate from $223.00 to $228.00 and gave the stock an “equal weight” rating in a research note on Friday. The Goldman Sachs Group restated a “buy” rating and set a $238.00 target price on shares of Allstate in a research note on Saturday. Keefe, Bruyette & Woods raised their price target on Allstate from $250.00 to $254.00 and gave the company an “outperform” rating in a report on Tuesday, January 6th. Finally, Mizuho upped their price objective on Allstate from $255.00 to $281.00 and gave the stock an “outperform” rating in a research note on Monday. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Allstate currently has a consensus rating of “Moderate Buy” and an average target price of $240.13.

Allstate Company Profile

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.